Alcyomics Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 13

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $2.82M

  • Investors
  • 1

Alcyomics General Information

Description

Operator of a pre-clinical assessment platform intended to support the pharmaceutical, biotechnology, and cosmetics industries. The company's platform offers sensitive detection of adverse immune reactions for preclinical testing of small- and large-molecule drugs and other compounds, enabling doctors and medical professionals to reduce risk and cost in the development of drugs and compounds.

Contact Information

Formerly Known As
Crossco (1014)
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • The Biosphere, Draymans Way
  • Newcastle Helix
  • Newcastle upon Tyne NE4 5BX
  • England, United Kingdom
+44 0191
Primary Industry
Other Pharmaceuticals and Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • The Biosphere, Draymans Way
  • Newcastle Helix
  • Newcastle upon Tyne NE4 5BX
  • England, United Kingdom
+44 0191

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alcyomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 05-Nov-2026 $2.82M Completed Generating Revenue
10. Secondary Transaction - Private Completed Generating Revenue
9. Accelerator/Incubator 01-Jan-2023 Completed Generating Revenue
8. Grant 04-Aug-2020 Completed Generating Revenue
7. Grant 01-Jan-2022 Completed Generating Revenue
6. Grant 01-Mar-2018 Completed Generating Revenue
5. Grant 01-Aug-2017 Completed Generating Revenue
4. Later Stage VC 21-Dec-2016 Completed Generating Revenue
3. Grant 15-Oct-2015 $179K Completed Generating Revenue
2. Grant 03-Sep-2013 $1.33M Completed Generating Revenue
To view Alcyomics’s complete valuation and funding history, request access »

Alcyomics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
B Ordinary
A Ordinary
To view Alcyomics’s complete cap table history, request access »

Alcyomics Patents

Alcyomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4473095-A1 An innervated cellular composite Pending 31-Jan-2022
GB-202201229-D0 An innervated cellular composite Inactive 31-Jan-2022
US-20250163373-A1 An innervated cellular composite Pending 31-Jan-2022
WO-2023144567-A1 An innervated cellular composite Inactive 31-Jan-2022
EP-4463539-A1 A cellular composite Pending 13-Jan-2022 C12N5/0655
To view Alcyomics’s complete patent history, request access »

Alcyomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alcyomics Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
EUREKA Network Accelerator/Incubator
Innovate UK Government
Newcastle University Endowment Limited Partner Minority
Northstar Ventures Venture Capital Minority
One North East Government Minority
You’re viewing 5 of 6 investors. Get the full list »

Alcyomics FAQs

  • When was Alcyomics founded?

    Alcyomics was founded in 2007.

  • Where is Alcyomics headquartered?

    Alcyomics is headquartered in Newcastle upon Tyne, United Kingdom.

  • What is the size of Alcyomics?

    Alcyomics has 13 total employees.

  • What industry is Alcyomics in?

    Alcyomics’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Alcyomics a private or public company?

    Alcyomics is a Private company.

  • What is the current valuation of Alcyomics?

    The current valuation of Alcyomics is .

  • What is Alcyomics’s current revenue?

    The current revenue for Alcyomics is .

  • How much funding has Alcyomics raised over time?

    Alcyomics has raised $564K.

  • Who are Alcyomics’s investors?

    EUREKA Network, Innovate UK, Newcastle University Endowment, Northstar Ventures, and One North East are 5 of 6 investors who have invested in Alcyomics.

  • When was Alcyomics acquired?

    Alcyomics was acquired on 05-Nov-2026.

  • Who acquired Alcyomics?

    Alcyomics was acquired by SenzaGen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process